CoChat

Semaglutide Use Prior to Total Hip Arthroplasty Results in Fewer Postoperative Prosthetic Joint Infections and Readmissions

Magruder, Matthew L., Miskiewicz, Michael J., Rodriguez, Ariel N., Mont, Michael A. · 2024 · The Journal of Arthroplasty
Cited by 92

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

BACKGROUND Semaglutide, a novel diabetes management medication, is known for its efficacy in inducing weight loss. Despite this, its impact on outcomes after total hip arthroplasty (THA) remains unclear. The aim of this study was to evaluate if THA patients on semaglutide demonstrate: 1) fewer medical complications; 2) fewer implant-related complications; 3) fewer readmissions; and 4) lower costs. METHODS Using a national claims database from 2010 to 2021, we retrospectively examined diabetic patients prescribed Semaglutide who underwent primary THA. This yielded 9,465 patients (Semaglutide=1,653; Control=7,812). Multivariable logistic regression was used to evaluate the following outcomes: 90-day post-operative medical complications, 2-year implant-related complications, 90-day readmissions, in-hospital lengths of stay, and day-of-surgery and 90-day episode of care costs. RESULTS Semaglutide users exhibited lower 90-day readmission rates (6.2% vs. 8.8%; OR 0.68; P<0.01) and reduced prosthetic joint infections (1.6% vs. 2.9%; OR 0.56; P<0.01). However, medical complication rates, hospital stays, same-day surgical costs, and 90-day episode costs showed no significant differences. CONCLUSION This study highlights Semaglutide users undergoing THA with fewer 90-day readmissions and 2-year prosthetic joint infections. Although no variance appeared in medical complications, hospital stays, or costs, the medication's notable glycemic control and weight loss benefits could prompt pre-surgery consideration. Further research is essential for a comprehensive understanding of Semaglutide's impact on post-THA outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.arth.2023.12.023

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 92

Metadata

Authors
Magruder, M. L., Miskiewicz, M. J., Rodriguez, A. N., & Mont, M. A.
Venue
The Journal of Arthroplasty
Publisher
Elsevier BV
Published
2024-03
Volume
39
Issue
3
Pages
716-720
ISSN
0883-5403 (ISSN-L)
OpenAlex
W4389955540
Cited by
92
References
8
FWCI
21.94
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Semaglutide Use Prior to Total Hip Arthroplasty Results in Fewer Postoperative Prosthetic Joint Infections and Readmissions. https://app.cochat.ai/papers/10.1016/j.arth.2023.12.023
The paper
Magruder, M. L., Miskiewicz, M. J., Rodriguez, A. N., & Mont, M. A. (2024). Semaglutide Use Prior to Total Hip Arthroplasty Results in Fewer Postoperative Prosthetic Joint Infections and Readmissions. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2023.12.023

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.